CitedEvidence
User Settings
Article

Examining opportunity for cancer clinical trial participation among under-represented groups

Jessica Rearden-2014-01-01-Scholarly Commons (University of Pennsylvania)
0

TL;DRAbstract

Recent evidence suggests racial/ethnic minorities, older adults and the economically disadvantaged are willing to participate in cancer clinical trials (CCTs) but may lack the opportunity to do so. We define opportunity for participation as an offer from a healthcare provider or researcher for screening and/or enrollment in a CCT. A barrier/promoter of opportunity for participation is eligibility, or the key attributes/characteristics a person must have in order to participate in a CCT. We have limited understanding of the roles of opportunity and eligibility for participation in CCTs and how this may contribute to under-representation. The primary objective of this dissertation was to examine whether opportunity and eligibility for cancer clinical trial participation differs between under-represented and well-represented groups based on socio-demographic and disease characteristics. Using Ford's conceptual framework for examining participation of under-represented groups in CCTs, we p

Chat with Paper

AI Agents for this Paper

Recent evidence suggests racial/ethnic minorities, older adults and the economically disadvantaged are willing to participate in cancer clinical trials (CCTs) but may lack the opportunity to do so. We define opportunity for participation as an offer from a healthcare provider or researcher for screening and/or enrollment in a CCT. A barrier/promoter of opportunity for participation is eligibility, or the key attributes/characteristics a person must have in order to participate in a CCT. We have limited understanding of the roles of opportunity and eligibility for participation in CCTs and how this may contribute to under-representation. The primary objective of this dissertation was to examine whether opportunity and eligibility for cancer clinical trial participation differs between under-represented and well-represented groups based on socio-demographic and disease characteristics. Using Ford's conceptual framework for examining participation of under-represented groups in CCTs, we p

Keywords

Medicine

Chat

Click to start Chat